Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Jaguar Health (JAGX) Return on Sales (2016 - 2025)

Jaguar Health (JAGX) has disclosed Return on Sales for 11 consecutive years, with 7.17% as the latest value for Q4 2025.

  • Quarterly Return on Sales fell 425.0% to 7.17% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 4.69% through Dec 2025, down 133.0% year-over-year, with the annual reading at 4.69% for FY2025, 133.0% down from the prior year.
  • Return on Sales for Q4 2025 was 7.17% at Jaguar Health, down from 3.13% in the prior quarter.
  • The five-year high for Return on Sales was 0.71% in Q4 2022, with the low at 908.2% in Q1 2022.
  • Average Return on Sales over 5 years is 74.14%, with a median of 4.36% recorded in 2023.
  • The sharpest move saw Return on Sales tumbled -54429bps in 2022, then soared 90177bps in 2023.
  • Over 5 years, Return on Sales stood at 6.71% in 2021, then skyrocketed by 89bps to 0.71% in 2022, then crashed by -468bps to 4.05% in 2023, then grew by 28bps to 2.92% in 2024, then crashed by -146bps to 7.17% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 7.17%, 3.13%, and 3.54% for Q4 2025, Q3 2025, and Q2 2025 respectively.